REVB
NASDAQ · Biotechnology
Revelation Biosciences Inc
$0.86
-0.01 (-1.25%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,088.2% upside
Low Target
$7.91
Average Target
$10.21
High Target
$15.75
Current Price
$0.86
Current
$0.86
$0.86
Target
$10.21
$10.21
$7.91
$10.21 avg
$15.75
Scenario Analysis
Bear Case
$7.91
820.5%
Low target
Base Case
$10.21
+1,088.2%
Avg target
Bull Case
$15.75
+1,732.9%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$6.76
-87.3% from high
52-Week Low
$0.86
+-0.1% from low
Target vs 52W High
$10.21
+51.0% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -3.3% |
| AMGN | Hold | 43 | 47% | $190.87 | -54.4% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +138.3% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -16.9% |
| REGN | Buy | 38 | 68% | $76.80 | -89.8% |
| MRNA | Hold | 30 | 37% | $149.45 | -24.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -65.3% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -43.4% |